Xylem reveals growth plan to expand MENA operations

Xylem reveals growth plan to expand MENA operations

NEWS Editorial Office: Elsevier Ltd The Boulevard, Langford Lane Kidlington, Oxford OX5 1GB, UK Tel: +44 1865 843239 Web: www.membrane-technology.com...

97KB Sizes 8 Downloads 59 Views

NEWS

Editorial Office: Elsevier Ltd The Boulevard, Langford Lane Kidlington, Oxford OX5 1GB, UK Tel: +44 1865 843239 Web: www.membrane-technology.com Executive Publisher: Laney Priestley Editor: Simon Atkinson Tel/Fax: +44 (0)1904 655944 Email: [email protected] Production Support Manager: Lin Lucas Email: [email protected] Editorial advisory board: Dr P Ball (Pall Europe), Dr D Bessarabov (HySA Infrastructure: NWU and CSIR), Prof. M Cheryan (University of Illinois at Urbana-Champaign), Prof. A G Fane (University of New South Wales), Dr A C M Franken (Membrane Application Centre Twente), Prof. E Gobina (Robert Gordon University), Dr A Merry (Aquious–PCI Membranes), Prof. M Nyström (Lappeenranta University of Technology), Dr Anil Pabby, Bhabha Atomic Research Centre, India Dr G K Pearce (Membrane Consultancy Associates), Prof. P H Pfromm (Kansas State University), Dr R W Philpott (Progenta Llp), Prof. R J Wakeman (Loughborough University of Technology), Prof. A Yaroshchuk (Ukrainian Membrane Society)

Subscription Information An annual subscription to Membrane Technology includes 12 issues and online access for up to 5 users. Prices: 1557 for all European countries & Iran US$1744 for all countries except Europe and Japan ¥206 700 for Japan Subscriptions run for 12 months, from the date payment is received. More information: http://store.elsevier.com/product.jsp?isbn=09582118 Permissions may be sought directly from Elsevier Global Rights Department, PO Box 800, Oxford OX5 1DX, UK; phone: +44 1865 843830, fax: +44 1865 853333, email: [email protected]. You may also contact Global Rights directly through Elsevier’s home page (www.elsevier.com), selecting first ‘Support & contact’, then ‘Copyright & permission’. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: +1 978 750 8400, fax: +1 978 750 4744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: +44 (0)20 7631 5555; fax: +44 (0)20 7631 5500. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution. Permission of the Publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the Publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the Publisher. Address permissions requests to: Elsevier Science Global Rights Department, at the mail, fax and email addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made.Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.

12978 Digitally Produced by Mayfield Press (Oxford) Limited

2

Membrane Technology

Patent awarded for MBR technology developed by CRIQ and INRS

A

US patent has been awarded jointly to Canada’s Centre de Recherche Industrielle du Québec (CRIQ) and Institut National de Recherche Scientifique (INRS) for a system and process that remove emerging micropollutants from industrial wastewater. In preliminary studies the patented membrane bioreactor (MBR) system eliminated 99% of bisphenol A (BPA) and other compounds in heavily contaminated wastewater. BPA, which is used in the manufacture of plastics, is a micropollutant thought to disrupt various physiological mechanisms. The system is designed to be installed at factory outlets to treat wastewater at the source, but it also can be incorporated into wastewater treatment plants. Further work conducted by INRS – a research-oriented branch of the Université du Québec, and CRIQ, a corporation dedicated to making Québec industry more competitive and boosting growth by supporting innovation, productivity and exports – is under way to confirm that this system can also treat water contaminated by six classes of drugs: antidepressants, antibiotics, analgesics, hormones, anticonvulsants and chemotherapy products. Its installation at hospital outlets would prevent these pollutants from dispersing into the environment, where they could have adverse effects and ultimately end up in the food chain. Université de Montréal, the Natural Sciences and Engineering Research Council of Canada, and Centre d’Expertise en Analyse Environnementale du Québec also contributed to the implementation of this project. ‘Since emerging micro-pollutants are not entirely eliminated by processes in existing wastewater treatment plants, CRIQ and its partners in 2008 began developing ways of enabling them to be removed before they reach municipal wastewater collection systems. Results indicate this is an especially promising approach towards protecting the environment from micro-pollutants, which carry real risks for human and animal health,’ noted Gerardo Buelna, research officer at CRIQ. Patrick Drogui, professor at Institut National de Recherche Scientifique, added: ‘The presence of micro-pollutants in effluents carries risks that justify research efforts. The technology developed by CRIQ and INRS, when installed directly at the source in hospitals, could reduce or even eliminate those risks.’

Contacts: Centre de Recherche Industrielle du Québec, 333 Franquet, Québec G1P 4C7, Canada. Tel: +1 418 659 1550, www.criq.qc.ca/en Institut National de la Recherche Scientifique, 490 rue de la Couronne, Québec G1K 9A9, Canada. Tel: +1 418 654 4677, www.inrs.ca

Xylem reveals growth plan to expand MENA operations

G

lobal water technology company Xylem Inc has pledged its commitment to an ambitious expansion plan, and investment of US$35 million in the Middle East and North Africa (MENA) region. It says the expansion will see increased localisation of products and involve building vital local capabilities, including manufacturing, which will provide customers with more highquality, efficient services and products. The company has invested in a number of facilities across the region, including a local manufacturing plant and offices in the United Arab Emirates, Oman and Qatar. Further investment will be made into expanding business services designed to provide customers with smarter technologies and products for their water technology needs. ‘The water–energy nexus is especially relevant throughout the MENA region,’ said Vincent Chirouze, Regional Director, Xylem Middle East and North Africa. ‘We view the low oil price environment as an opportunity to invest and expand in this market whilst many of our competitors are being cautious or even limiting their investments. As the Middle East works hard to address long-term water security in the region, we are positioning ourselves for long-term growth and success.’ In addition, Xylem seeks through its expansion plan to create strategic partnerships with government and private entities to address pressing regional water issues. Xylem and the Masdar Institute of Science and Technology recently announced a research collaboration to establish sustainability indicators such as energy and cost performance of processes and equipment for water and wastewater treatment, and water transport facilities in Abu Dhabi. A critical component of the firm’s bold growth plans in the region is a significant investment in a local manufacturing plant in Dubai. The facility will bring new jobs to the region and provide the market with locally engineered products and services. In 2015, Xylem doubled its local team to support its ambitious growth

March 2016

NEWS/IN BRIEF plan. Furthermore, the facility will host a training and learning centre, providing training to engineers, contractors and installers in the proper design, installation and maintenance of water-related systems and technology. Xylem moves to the new office in Dubai later this year. It will serve as the headquarters for its regional operations. Contact: Xylem Inc, 1 International Drive, Rye Brook, NY 10573-1058, USA. Tel: +1 914 3041700, www.xyleminc.com

Kubota receives order to supply SMUs for MBR project in Oman

K

ubota Membrane Europe Ltd (KME), a subsidiary of Japan’s Kubota Corp, has received an order from Korea’s Doosan Heavy Industries Co Ltd to supply Submerged Membrane Units (SMUs), which will be used to upgrade the Al Ansab sewage treatment plant (STP) in Muscat City, Oman. Because the city is a rapidly developing residential and commercial area, the capacity of the existing STP needs to be expanded. Kubota’s SMUs have been employed at the existing STP for Phase I. They have been stable and produced water that complies with strict regulations ever since they started operating in 2010. The firm says the SMUs are easy to operate and maintain, and together with the unique after service that it provides, are the main reasons why they have been chosen for this expansion project (Phase II). The work needed to increase the facility’s capacity to 120 000 m3/d is scheduled to be completed in August 2017. Many countries in the Middle East have the same problem as Oman. According to Kubota, MBRs are seldom selected for large-scale sewage treatment because there are few references for this technology. It is planning to develop the large-size MBR market in the Middle East using this reference and operational data from the Canton Water Reclamation Facility in Ohio, USA, (160 000 m³/d) which uses its technology (also see Membrane Technology, August, page 16). Contact: Kubota Corp, 2–47, Shikitsuhigashi 1-chome, Naniwa-ku, Osaka 556-8601, Japan. Tel: +81 6 6648 2111, www.kubota-global.net Kubota Membrane Europe, 3rd Floor Horatio House, No. 1 Farrier’s Yard, 77–85 Fulham Palace Road,

March 2016

London, W6 8JA, UK. Tel: +44 208 741 5262, www.kubota-mbr.com

Kerui – first Chinese company to export nitrogen generators to the USA

K

erui Group recently shipped its single skid-mounted 1200-Nm3/h nitrogen generator to the USA, following a week-long evaluation by the client. The company says that this is the first membrane-separation nitrogen generation system for use in “oil stimulation” to be exported from China to USA. The system sold to the US client is not based on the traditional double truck-mounted or double skid-mounted design, says Kerui. It integrates the air compressor with the gas booster and uses a high-output engine to drive continuous and efficient nitrogen injection, greatly cutting the operating cost and work space for the client, and making the operation easier and safer. In order to meet the client’s requirements perfectly, Kerui customised the nitrogen generator in various ways. For example, the control interface provides several language options, including Chinese, English and Russian, to guarantee a good user-experience in multilingual scenarios. It also developed a heating upon power-up system for the three core components, namely the air compressor, the engine and the gas booster, and improved the locking system of the shell door. The USA currently holds a dominating position in the field of high-end oil development, oil equipment manufacturing and oil service technologies, making it difficult for products and services offered by developing countries to enter the market place. Kerui says that as a private oil and gas company, which is looking at markets outside China, it has been focusing on innovation and enhancement of its manufacturing capability, and has achieved great success. It has become a major provider of nitrogen-injection technology for oil stimulation, nitrogen generation system manufacturing and nitrogen injection services, which take a 70% share in the Chinese market. It is also carrying out business in Colombia, Peru, Kazakhstan and Kuwait.

Contact: Kerui Petroleum, No. 233 Naner Road, Dongying City Dongying, Shandong 257000, China. Tel: +86 180 5465 2098, www.keruigroup.com.cn/en

In Brief KMS makes changes to its executive management Manny Singh and Mark Farrell have been appointed President, and Chief Operating Officer, Koch Membrane Systems Inc (KMS), respectively. The US-based developer and producer of membranes and membrane-based filtration systems, says Singh has been its senior vice president of technology for the last five years, and was responsible for development and commercialisation of a number of new products for both the Water and Wastewater, and Industrial and Life Sciences businesses. More recently, under his guidance, KMS launched the Pulsion next-generation MBR and Dairy-Pro product lines. Farrell has been with KMS for 15 years in multiple engineering and leadership roles – most recently serving as its vice president of global manufacturing and engineering. Ovivo awarded two major UPW projects Water and wastewater treatment company Ovivo Inc has been awarded two large contracts, with a combined value of over $14 million, in the electronics market in Canada and Asia. The first contract involves designing and supplying ultrapure water (UPW) systems, including the extension of the current UPW and distribution loop capacity of a plant, as well as adding process and equipment technology for reclaiming water. The delivery of the system is scheduled for the end of 2016. The second contract is to provide UPW equipment and services for capacity expansion, including a high-purity polishing system. The delivery of this project is scheduled for April 2016. Coal-to-chemicals conversion project uses Aquatech’s systems Aquatech International Corp, which specialises in water and wastewater technologies for the industrial and infrastructure markets, has been awarded a contract to provide a water treatment facility that includes wastewater recycling and zero liquid discharge systems for a coal-to-chemicals conversion project that is being developed by the Chinacoal Group – China’s second largest coal producer. This is the second such plant that has been awarded to Aquatech by Chinacoal at the same location in Ordos City, Inner Mongolia. Aquaporin membrane featured in film Aquaporin Inside membrane technology was one of the sustainable materials covered in a documentary film entitled ‘The Secret Life of Materials’, which is part of the EU-FP7-funded education project ‘Materials 4 A Sustainable Future’ that aims to reveal the importance of advanced materials in our everyday lives.

Membrane Technology

3